Company: VEEV
Filing Date: 2025-11-21
Form Type: 10-Q
Source: 0001393052-25-000078
Chunk: 141

Company: VEEVA SYSTEMS INC
Filing Date: 2025-11-21
Form: 10-Q
Item: Part I, Item 1
Chunk 141
---
(6,170)(7,131)Other long-term liabilities4,028 3,695 Net cash provided by operating activities1,308,378 1,020,507 Cash flows from investing activitiesPurchases of short-term investments(2,386,193)(2,206,521)Maturities and sales of short-term investments1,471,683 1,537,874 Long-term assets(22,102)(15,799)Net cash used in investing activities(936,612)(684,446)Cash flows from financing activitiesProceeds from exercise of common stock options239,996 65,104 Taxes paid related to net share settlement of equity awards(71,281)(59,800)Net cash provided by financing activities168,715 5,304 Effect of exchange rate changes on cash, cash equivalents, and restricted cash871 (1,346)Net change in cash, cash equivalents, and restricted cash541,352 340,019 Cash, cash equivalents, and restricted cash at beginning of period1,120,963 706,670 Cash, cash equivalents, and restricted cash at end of period$1,662,315 $1,046,689 Cash, cash equivalents, and restricted cash at end of period:Cash and cash equivalents$1,660,137 $1,044,511 Restricted cash included in other long-term assets2,178 2,178 Total cash, cash equivalents, and restricted cash at end of period$1,662,315 $1,046,689 Supplemental disclosures of other cash flow information:Cash paid for income taxes, net of refunds$164,908 $238,935 Excess tax benefits from employee stock plans$23,302 $5,160 

See Notes to Condensed Consolidated Financial Statements.

Veeva Systems Inc. | Form 10-Q7

Table of Contents

VEEVA SYSTEMS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Summary of Business and Significant Accounting Policies 

Description of BusinessVeeva is the leading provider of industry cloud solutions for the global life sciences industry. Our offerings span cloud software, data, and business consulting and are designed to meet the unique needs of our customers and their most strategic business functions—from research and development (“R&D”) through commercialization. Our solutions help life sciences companies develop and bring